Article info
Liver
Review
Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy
- Correspondence to Dr Alan Bonder, Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA; abonder{at}bidmc.harvard.edu
Citation
Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy
Publication history
- Received October 10, 2018
- Revised December 4, 2018
- Accepted December 9, 2018
- First published January 9, 2019.
Online issue publication
April 09, 2020
Article Versions
- Previous version (6 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.